Medicare Enrolled
Dr. Luis Camacho, M.D., MPH
Hematology & Oncology · Houston, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Camacho from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Camacho?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Camacho
Dr. Luis Camacho is a hematology & oncology specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Camacho performed 11,739 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Camacho received a total of $357,785 from 62 pharmaceutical and/or device companies across 871 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Camacho is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 36% volume in TX
$357,785 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗11,739
Medicare services
Top 36% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
9,900 | $0 | $2 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
622 | $0 | $2 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
227 | $132 | $350 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
195 | $90 | $300 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
156 | $12 | $50 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
141 | $0 | $26 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
128 | $96 | $560 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
67 | $1 | $5 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
53 | $30 | $150 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
40 | $50 | $239 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
39 | $17 | $80 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
38 | $140 | $750 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
30 | $3 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $127 | $315 |
| New patient office visit, complex (60-74 min) | 24 | $178 | $700 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $105 | $650 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $69 | $210 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
15 | $132 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.9% high complexity
92.4% medium
5.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$357,785
Total received (2018-2024)
Avg $51,112/year across 7 years
Top 2% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
871
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$30,121
2023
$30,992
2022
$42,307
2021
$11,591
2020
$33,258
2019
$107,763
2018
$101,752
Payments by company (2024)
Merck Sharp & Dohme LLC
$28,581
Exelixis Inc.
$178
Janssen Biotech, Inc.
$177
Medtronic, Inc.
$140
Celgene Corporation
$107
Janssen Pharmaceuticals, Inc
$81
Lilly USA, LLC
$78
Aveo Pharmaceuticals, Inc.
$75
AstraZeneca Pharmaceuticals LP
$72
Eisai Inc.
$66
Alexion Pharmaceuticals, Inc.
$57
Incyte Corporation
$56
E.R. Squibb & Sons, L.L.C.
$48
Daiichi Sankyo Inc.
$48
GENZYME CORPORATION
$42
Astellas Pharma US Inc
$40
Amgen Inc.
$37
Rigel Pharmaceuticals, Inc.
$34
PharmaEssentia USA Corporation
$31
BeiGene USA, Inc.
$26
Regeneron Pharmaceuticals, Inc.
$24
ABBVIE INC.
$23
Gilead Sciences, Inc.
$22
GlaxoSmithKline, LLC.
$21
Pharming Healthcare, Inc.
$20
PFIZER INC.
$19
Bayer Healthcare Pharmaceuticals Inc.
$19
Top 3 companies account for 96.1% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$170,288
Merck Sharp & Dohme LLC
$92,761
Amgen Inc.
$75,856
Exelixis Inc.
$8,274
PFIZER INC.
$2,759
AstraZeneca Pharmaceuticals LP
$965
Lilly USA, LLC
$638
Celgene Corporation
$598
E.R. Squibb & Sons, L.L.C.
$473
Medtronic, Inc.
$447
Medtronic Vascular, Inc.
$349
Genentech USA, Inc.
$339
Bayer HealthCare Pharmaceuticals Inc.
$256
Astellas Pharma US Inc
$228
Incyte Corporation
$223
Eisai Inc.
$222
BeiGene USA, Inc.
$221
Janssen Biotech, Inc.
$218
Teva Pharmaceuticals USA, Inc.
$182
Seagen Inc.
$170
Daiichi Sankyo Inc.
$165
GENZYME CORPORATION
$157
Pharmacyclics LLC, An AbbVie Company
$151
Rigel Pharmaceuticals, Inc.
$127
Janssen Pharmaceuticals, Inc
$108
SECURA BIO, INC.
$90
ABBVIE INC.
$83
PharmaEssentia USA Corporation
$78
EMD Serono, Inc.
$78
Aveo Pharmaceuticals, Inc.
$75
AMAG Pharmaceuticals, Inc.
$73
AVEO Pharmaceuticals, Inc.
$73
Taiho Oncology, Inc.
$61
EISAI INC.
$60
Alexion Pharmaceuticals, Inc.
$57
MorphoSys, US Inc.
$55
Novartis Pharmaceuticals Corporation
$51
Mylan Institutional Inc.
$49
Ipsen Biopharmaceuticals, Inc
$48
Lexicon Pharmaceuticals, Inc.
$48
Kyowa Kirin, Inc.
$46
Karyopharm Therapeutics Inc.
$45
GlaxoSmithKline, LLC.
$45
TerSera Therapeutics LLC
$44
Verastem, Inc.
$44
Mirati Therapeutics, Inc.
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
Bayer Healthcare Pharmaceuticals Inc.
$37
Puma Biotechnology, Inc.
$36
Secura Bio, Inc.
$28
AbbVie Inc.
$26
ARRAY BIOPHARMA INC
$24
Regeneron Pharmaceuticals, Inc.
$24
Gilead Sciences, Inc.
$22
Dova Pharmaceuticals
$21
Pharming Healthcare, Inc.
$20
Spectrum Pharmaceuticals Inc.
$18
Sun Pharmaceutical Industries Inc.
$16
Seattle Genetics, Inc.
$15
Agios Pharmaceuticals, Inc.
$14
Acrotech Biopharma LLC
$12
INSYS Therapeutics Inc
$12
Top 3 companies account for 94.7% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ALIMTA · Abraxane · Alecensa · Aranesp · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · COPIKTRA · COREVALVE EVOLUT R · CYRAMZA · Cabometyx · Copiktra · CoreValve Evolut · DARZALEX · DAURISMO · Doptelet · ELIQUIS · EMEND · ENHERTU · ERBITUX · ERLEADA · Enhertu · FARYDAK · FERAHEME · FOTIVDA · Folotyn · Fulphila · GILOTRIF · IBRANCE · IMFINZI · IN.PACT Admiral · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KRAZATI · Kyprolis · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · PADCEV · POTELIGEO · Padcev · Pomalyst · Prolia · REBLOZYL · RETEVMO · RUCONEST · Revlimid · Rezlidhia · SARCLISA · SOMATULINE DEPOT · SUTENT · SYNDROS · Stivarga · TAGRISSO · TECENTRIQ · TEFLARO · TIBSOVO · TUKYSA · Tavalisse · Truxima · ULTOMIRIS · VENCLEXTA · VERZENIO · VenaSeal · WELIREG · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · YONSA · ZOLADEX
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
202
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Camacho is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Camacho experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Camacho performed 9,900 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Camacho receive payments from pharmaceutical companies?
Yes. Dr. Camacho received a total of $357,785 from 62 companies across 871 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Camacho's costs compare to other hematology & oncology specialists in Houston?
Dr. Camacho's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Camacho) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Houston
Browse hematology & oncology specialists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology